Skip to main content
OpenTrials

Clinical trial condition

Neoplastic Processes

Explore clinical trials studying Neoplastic Processes. Study availability and eligibility vary by location and protocol.

3,272 public trials 686 recruiting studies
Refine in advanced search Browse all conditions

Neoplastic Processes trial results

Completed

Sorafenib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Leukemia

NCT01445080

Conditions
Blast Crisis, Blastic Phase, Bone Marrow Diseases, +33 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Children's Hospital of Orange County Orange, California, United States
  • Lucile Packard Children's Hospital Stanford University Palo Alto, California, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
View all 25 locations
View Trial Details
Completed

Perioperative Chemotherapy Plus Cetuximab Versus Chemotherapy Alone for High Risk Resectable Colorectal Liver Metastasis

NCT03031444

Conditions
Colonic Diseases, Colorectal Cancer Stage IV, Colorectal Neoplasms, +14 more
Locations
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
  • West China Hospital, Sichuan University Chengdu, Sichuan, China
  • First Affiliated Hospital of Kunming Medical University Kunming, Yunnan, China
  • Zhejiang Cancer Hospital Hangzhou, Zhejiang, China
View Trial Details
Completed

Intermittent High-Dose Lapatinib in Tandem With Capecitabine for HER2 Overexpressed/Amplified Metastatic Breast Cancer With Central Nervous System (CNS) Metastases

NCT02650752

Conditions
Breast Diseases, Breast Neoplasms, Central Nervous System (CNS) Metastases, +9 more
Locations
  • University of Michigan Health System Ann Arbor, Michigan, United States
  • Memoral Sloan Kettering Cancer Center Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States
  • Memorial Sloan Kettering Cancer Center @ Suffolk Commack, New York, United States
View Trial Details
Completed

A Study of Ramucirumab (LY3009806) Plus MEDI4736 in Participants With Advanced Gastrointestinal or Thoracic Malignancies

NCT02572687

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +28 more
Locations
  • UCLA Medical Center Santa Monica, California, United States
  • Johns Hopkins University Baltimore, Maryland, United States
  • Washington University Medical Center St Louis, Missouri, United States
  • Carolinas Medical Center Charlotte, North Carolina, United States
View all 28 locations
View Trial Details

Related conditions